The Hidden Chaos Behind Beautiful Bioinformatics Figures
1/15 You only see the final beautiful figure in that bioinformatics paper. But behind every clean heatmap lies a storm of trials, errors, and late-night debugging sessions.
3/15 RNA-seq analysis. PI: "Just run differential expression and get me the pathways." Reality: 50 emails debating fold-change cutoffs, p-value adjustments, and whether DESeq2 or edgeR is better.
In a secondary analysis of a trial of TBI patients on antiplatelet therapies receiving platelet transfusions, VerifyNow and TEG-PM do not detect differences to platelet function between patients receiving cold-stored and room temperature platelet units.
@jrkillinger99@macky_neal@PittSurgery@PittTTMRC@PittNeurosurg
https://t.co/ofK0tknVER
In a secondary analysis of a trial of TBI patients on antiplatelet therapies receiving platelet transfusions, VerifyNow and TEG-PM do not detect differences to platelet function between patients receiving cold-stored and room temperature platelet units.
@jrkillinger99@macky_neal@PittSurgery@PittTTMRC@PittNeurosurg
https://t.co/ofK0tknVER
In a secondary analysis of a trial of TBI patients on antiplatelet therapies receiving platelet transfusions, VerifyNow and TEG-PM do not detect differences to platelet function between patients receiving cold-stored and room temperature platelet units.
@jrkillinger99@macky_neal@PittSurgery@PittTTMRC@PittNeurosurg
https://t.co/ofK0tknVER
Watch an overview of "Predictive value of platelet function assays in traumatic brain injury patients on antiplatelet therapy" presented by Dr. Neal!🎬
https://t.co/vDVKL81soX
❇️Best of Trauma❇️
Read the article "Predictive value of platelet function assays in traumatic brain injury patients on antiplatelet therapy"
https://t.co/oM8MfokAM9
In an RCT of TBI patients on antiplatelet therapy, higher absolute TEG-PM values predicted better clinical outcomes. VerifyNow ASA showed improvement after transfusion. Transfusion-induced assay changes were not associated with clinical outcomes.
https://t.co/oM8MfokAM9
A new article in The @NewYorker highlights the @NHSBT-led RESTORE trial, the first in the world to transfuse lab-grown red blood cells into people. https://t.co/ItaLLv4kge
Dr. Khandaker from my lab gave an update on the CHIPSiv study comparing room temp vs cold stored #platelets - looking pretty good in vitro out to 21 days across multiple platforms! @PittTTMRC@PittSurgery
So so so happy to share that my first, first-author paper from my time at @NIMHgov is now available online at Journal of Neurodevelopmental Disorders!
https://t.co/Mr9ggo9Uw1
See below for a 🧵of key findings... 1/
ASD and ADHD share considerable genetic overlap. Here, we disentangle this shared genetic basis and investigate the unique genetic pathways for ASD persisting independently of ADHD. We find genetic links with psych d/o's, cognition, transcriptome, and more! More deets below! 🧬🧠
🚨 New preprint from IBG graduate student @Lukas_Schaffe that examines the genetic signal in autism spectrum disorder (ASD) that is unique of ADHD. Findings reveal clinical correlates, genes, and biological pathways unique to ASD. https://t.co/vnMOTjImtO
so grateful to present my work on the unique genetics of autism at my first ever #BGA2024 ! even better that I got to do so alongside some fantastic early career researchers in neurodevelopmental genetics :)
Honored to have had the opportunity to present @ISTH in #Bangkok this year and grateful for those (@macky_neal@SMSheaLab@PittTTMRC) who made it possible. Looking forward to many more ISTHs to come. (Post delayed due to post-conference vacation fun in #Phuket with @rahn_kate)